Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Claire L Townsend"'
Autor:
Heather Bailey, Claire L Townsend, Igor Semenenko, Ruslan Malyuta, Mario Cortina-Borja, Claire Thorne
Publikováno v:
Bulletin of the World Health Organization, Vol 91, Iss 7, Pp 491-500 (2013)
OBJECTIVE: To investigate the scale-up of antenatal combination antiretroviral therapy (cART) in Ukraine since this became part of the national policy for the prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV). M
Externí odkaz:
https://doaj.org/article/11f4a692b9774698aaf512f4db88d1a9
Autor:
Heather Bailey, Claire Thorne, Igor Semenenko, Ruslan Malyuta, Rostislav Tereschenko, Irina Adeyanova, Elena Kulakovskaya, Lyudmila Ostrovskaya, Liliana Kvasha, Mario Cortina-Borja, Claire L Townsend
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e34706 (2012)
HIV-positive women have an increased risk of invasive cervical cancer but cytologic screening is effective in reducing incidence. Little is known about cervical screening coverage or the prevalence of abnormal cytology among HIV-positive women in Ukr
Externí odkaz:
https://doaj.org/article/8d10088d119245f19be3c861bb3c0e04
Autor:
John O'Rourke, Claire L. Townsend, Edith Milanzi, Intira Jeannie Collins, Hannah Castro, Ali Judd, Marissa Vicari, Julie Jesson, Valériane Leroy, Martina Penazzato, Françoise Renaud
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 2, Pp n/a-n/a (2023)
Abstract Introduction Tenofovir alafenamide (TAF) is approved for paediatric use in fixed‐dose combination tablets, but efficacy and safety data in children are limited. We conducted a systematic review on the efficacy/effectiveness and safety of T
Externí odkaz:
https://doaj.org/article/506a2793526a41bba159fa5b9a5617fe
Autor:
Claire L. Townsend, John O'Rourke, Edith Milanzi, Intira Jeannie Collins, Ali Judd, Hannah Castro, Marissa Vicari, Julie Jesson, Valériane Leroy, Françoise Renaud, Martina Penazzato
Publikováno v:
Journal of the International AIDS Society, Vol 25, Iss 11, Pp n/a-n/a (2022)
Abstract Introduction Globally about 1.7 million children were living with HIV in 2020. Two integrase strand transfer inhibitors, dolutegravir and raltegravir, are increasingly used in children. We conducted a systematic review to assess the effectiv
Externí odkaz:
https://doaj.org/article/97ab22fa53bd4558b5894ef106f79983
Autor:
Laura Saint-Lary, Marc Harris Dassi Tchoupa Revegue, Julie Jesson, Françoise Renaud, Martina Penazzato, Claire L. Townsend, John O'Rourke, Valériane Leroy, WHO HIV Hepatitis and STIs (HHS) Department
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
BackgroundAtazanavir/ritonavir is recommended as a preferred second-line antiretroviral regimen in children older than 3 months, alternatively to lopinavir/ritonavir. We performed a systematic review to assess safety and effectiveness of atazanavir u
Externí odkaz:
https://doaj.org/article/18297fa7b565466eb628c43289b0646d
Autor:
Julie, Jesson, Laura, Saint-Lary, Marc Harris Dassi Tchoupa, Revegue, John, O'Rourke, Claire L, Townsend, Françoise, Renaud, Martina, Penazzato, Valériane, Leroy
Publikováno v:
The Lancet Child & Adolescent Health. 6:692-704
Abacavir is a nucleoside reverse transcriptase inhibitor recommended in paediatric HIV care. We assessed the safety and efficacy profile of abacavir used in first, second, or subsequent lines of treatment for infants, children, and adolescents living
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7dc1c9d1aed7add80969123ed742a95
https://doi.org/10.1016/s2352-4642(22)00213-9
https://doi.org/10.1016/s2352-4642(22)00213-9
Autor:
Martina Penazzato, Claire L Townsend, Nadia A Sam-Agudu, Theodore D Ruel, Moherndran Archary, Adrie Bekker, Tim R Cressey, Angela Colbers, Nandita Sugandhi, Pablo Rojo, Natella Rakhmanina, Melynda Watkins, Lisa Frigati, Irene Mukui, Asma Hafiz, Marissa Vicari, Edmund V Capparelli, Elaine J Abrams, Elaine Abrams, Edmund Capparelli, Tim Cressey, Theodore Ruel, Nadia Sam-Agudu, Claire Townsend
Publikováno v:
The Lancet HIV, 9, 9, pp. e658-e666
The Lancet HIV, 9, e658-e666
The Lancet HIV, 9, e658-e666
Item does not contain fulltext Safe and effective paediatric formulations of the most promising antiretroviral drugs are crucial to advance the treatment and prevention of HIV in neonates, infants, children, and adolescents. The WHO Paediatric Drug O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76dda77c0dae2f90172e4490f05051b1
https://pubmed.ncbi.nlm.nih.gov/35863362
https://pubmed.ncbi.nlm.nih.gov/35863362
Autor:
Martina Penazzato, Claire L Townsend, Natella Rakhmanina, Yao Cheng, Moherndran Archary, Tim R Cressey, Maria H Kim, Victor Musiime, Anna Turkova, Theodore D Ruel, Helena Rabie, Nandita Sugandhi, Pablo Rojo, Meg Doherty, Elaine J Abrams, Elaine Abrams, Jintanat Ananworanich, Isabelle Andrieux-Meyer, Yodit Belew, Brookie Best, Rosa Bologna, Jessica Burry, Deborah Carpenter, Polly Clayden, Angela Colbers, Magda Conway, Timothy R. Cressey, Mutsa Dangarembizi, Shaffiq Essajee, Maribel Gonzalez Tome, Andrew Hill, Saye Khoo, Maria Kim, Linda Lewis, Janice Lee, Shahin Lockman, Imelda Mahaka, Mark H. Mirochnick, Lynne Mofenson, Mireille Muhimpundu, Angela Mushavi, Elizabeth Obimbo, Fernando Pascual, Carmen Perez Casas, Anton Pozniak, Theodore Ruel, Jonathan Schapiro, George Siberry, Teresa Beatriz Simione, Cheick Tidiane Tall, Francois Venter, Marissa Vicari, Jenny Walsh, Jacque Wambui, Melynda Watkins
Publikováno v:
Lancet HIV. 6(9):e623-e631
Despite considerable progress in paediatric HIV treatment and timely revision of global policies recommending the use of more effective and tolerable antiretroviral regimens, optimal antiretroviral formulations for infants, children, and adolescents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f20637fa850df8d53b10953c843a6e8b
https://doi.org/10.1016/s2352-3018(19)30193-6
https://doi.org/10.1016/s2352-3018(19)30193-6
Autor:
Sharon Nachman, Jane McKenzie-White, Moherndren Archary, Kimberly A Struble, Polly Clayden, Charles Flexner, Shahin Lockman, Kenneth H. Mayer, Edmund V. Capparelli, Mark Mirochnick, Claire L Townsend, Patrick Jean-Philippe, Elaine J. Abrams, Heather Watts
Publikováno v:
The Lancet. HIV
Summary Antiretroviral agents with long-acting properties have potential to improve treatment outcomes substantially for people living with HIV. In November 2017, the Long acting/Extended Release Antiretroviral Resource Program (LEAP) convened a work
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fa9e5dd34d4d3b747d8e29e609f8700
http://europepmc.org/articles/PMC7152795
http://europepmc.org/articles/PMC7152795
Autor:
David M. Burger, Martina Penazzato, Stein Schalkwijk, Mark Mirochnick, Claire L Townsend, Angela Colbers
Publikováno v:
Clinical Infectious Diseases, 69, 7, pp. 1254-1258
Clinical Infectious Diseases, 69, 1254-1258
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 69, 1254-1258
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Recently, the US Food and Drug Administration and European Medicines Agency issued warnings on the use of dolutegravir and darunavir/cobicistat for treatment of pregnant women living with human immunodeficiency virus (HIV). It took 3–5 years to ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24c45b86a57fdd36ade1210f89b30c13
https://doi.org/10.1093/cid/ciz121
https://doi.org/10.1093/cid/ciz121